Chemokine receptor 5 △32 allele in patients with severe pandemic (H1N1) 2009.

dc.contributor.author	Keynan, Y
dc.contributor.author	Juno, J
dc.contributor.author	Meyers, A
dc.contributor.author	Ball, TB
dc.contributor.author	Kumar, A
dc.contributor.author	Rubinstein, E
dc.contributor.author	Fowke, KR.
dc.date.accessioned	2013-11-26T16:29:37Z
dc.date.available	2013-11-26T16:29:37Z
dc.date.issued	2010-10
dc.identifier.citation	Emerg Infect Dis. 2010 Oct;16(10):1621-2. doi: 10.3201/eid1610.100108.	en
dc.identifier.uri	http://www.ncbi.nlm.nih.gov/pubmed/20875295
dc.identifier.uri	http://hdl.handle.net/11295/60619
dc.description.abstract	Because chemokine receptor 5 (CCR5) may have a role in pulmonary immune response, we explored whether patients with severe pandemic (H1N1) 2009 were more likely to carry the CCR5Δ32 allele than were members of the general population. We found a large proportion of heterozygosity for the CCR5Δ32 allele among white patients with severe disease.	en
dc.language.iso	en	en
dc.publisher	University of Nairobi	en
dc.title	Chemokine receptor 5 △32 allele in patients with severe pandemic (H1N1) 2009.	en
dc.type	Article	en
local.publisher	Department of Medical Microbiology,	en